| Dr Kieren Patrick Knapp, DO | |
|
55 N Main St, Jacobus, PA 17407-1248 | |
| (717) 428-1911 | |
| (717) 428-2519 |
| Full Name | Dr Kieren Patrick Knapp |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 45 Years |
| Location | 55 N Main St, Jacobus, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417911652 | NPI | - | NPPES |
| 0006577120001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS-OO4435-L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellspan Vna Home Care | York, PA | Home health agency |
| York Hospital | York, PA | Hospital |
| Upmc Memorial | York, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
Vocera Communications, Inc., the leading provider of solutions that address critical communications and productivity challenges facing healthcare, hospitality, retail and other mobile work environments, today announced that its founder and chief technology officer, Robert Shostak, PhD, has been awarded the 2013 Jean-Claude Laprie Award in Dependable Computing for his co-authored paper, "The Byzantine Generals Problem".
Preterm infants who demonstrate uncoordinated sucking patterns during feeding could have neurologic dysfunction, research suggests.
Following the recently announced success achieved during the third round of trials at its research facility at Queen's University (Kingston Ontario, Canada) Medizone International, Inc. announces that a second patent application has been filed which in combination with its previous patent application for AsepticSure™ filed in July of 2009, affords the Company greatly enhanced protection for both the hospital version of AsepticSure™ and the government variant intended for bio-terrorism countermeasures.
According to experts a simple DNA test for Down syndrome could save nearly all pregnant women from invasive tests like amniocentesis. Usually 3% to 5% of pregnant women in the UK or some 30,000 women have to undergo invasive tests like amniocentesis that increases the risk of miscarriage to 1%. The new DNA blood test could bring this down to 0.1%, according to a study in the British Medical Journal.
The head of the U.S. Food and Drug Administration has proposed charging compounding pharmacies fees to pay for the oversight needed to prevent a recurrence of the meningitis outbreak that killed 50 people and sickened hundreds more.
› Verified 3 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
Vocera Communications, Inc., the leading provider of solutions that address critical communications and productivity challenges facing healthcare, hospitality, retail and other mobile work environments, today announced that its founder and chief technology officer, Robert Shostak, PhD, has been awarded the 2013 Jean-Claude Laprie Award in Dependable Computing for his co-authored paper, "The Byzantine Generals Problem".
Preterm infants who demonstrate uncoordinated sucking patterns during feeding could have neurologic dysfunction, research suggests.
Following the recently announced success achieved during the third round of trials at its research facility at Queen's University (Kingston Ontario, Canada) Medizone International, Inc. announces that a second patent application has been filed which in combination with its previous patent application for AsepticSure™ filed in July of 2009, affords the Company greatly enhanced protection for both the hospital version of AsepticSure™ and the government variant intended for bio-terrorism countermeasures.
According to experts a simple DNA test for Down syndrome could save nearly all pregnant women from invasive tests like amniocentesis. Usually 3% to 5% of pregnant women in the UK or some 30,000 women have to undergo invasive tests like amniocentesis that increases the risk of miscarriage to 1%. The new DNA blood test could bring this down to 0.1%, according to a study in the British Medical Journal.
The head of the U.S. Food and Drug Administration has proposed charging compounding pharmacies fees to pay for the oversight needed to prevent a recurrence of the meningitis outbreak that killed 50 people and sickened hundreds more.
› Verified 3 days ago
| Entity Name | Jacobus Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124145313 PECOS PAC ID: 1557546298 Enrollment ID: O20110425000201 |
News Archive
Vocera Communications, Inc., the leading provider of solutions that address critical communications and productivity challenges facing healthcare, hospitality, retail and other mobile work environments, today announced that its founder and chief technology officer, Robert Shostak, PhD, has been awarded the 2013 Jean-Claude Laprie Award in Dependable Computing for his co-authored paper, "The Byzantine Generals Problem".
Preterm infants who demonstrate uncoordinated sucking patterns during feeding could have neurologic dysfunction, research suggests.
Following the recently announced success achieved during the third round of trials at its research facility at Queen's University (Kingston Ontario, Canada) Medizone International, Inc. announces that a second patent application has been filed which in combination with its previous patent application for AsepticSure™ filed in July of 2009, affords the Company greatly enhanced protection for both the hospital version of AsepticSure™ and the government variant intended for bio-terrorism countermeasures.
According to experts a simple DNA test for Down syndrome could save nearly all pregnant women from invasive tests like amniocentesis. Usually 3% to 5% of pregnant women in the UK or some 30,000 women have to undergo invasive tests like amniocentesis that increases the risk of miscarriage to 1%. The new DNA blood test could bring this down to 0.1%, according to a study in the British Medical Journal.
The head of the U.S. Food and Drug Administration has proposed charging compounding pharmacies fees to pay for the oversight needed to prevent a recurrence of the meningitis outbreak that killed 50 people and sickened hundreds more.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kieren Patrick Knapp, DO 55 N Main St, Jacobus, PA 17407-1248 Ph: (717) 428-1911 | Dr Kieren Patrick Knapp, DO 55 N Main St, Jacobus, PA 17407-1248 Ph: (717) 428-1911 |
News Archive
Vocera Communications, Inc., the leading provider of solutions that address critical communications and productivity challenges facing healthcare, hospitality, retail and other mobile work environments, today announced that its founder and chief technology officer, Robert Shostak, PhD, has been awarded the 2013 Jean-Claude Laprie Award in Dependable Computing for his co-authored paper, "The Byzantine Generals Problem".
Preterm infants who demonstrate uncoordinated sucking patterns during feeding could have neurologic dysfunction, research suggests.
Following the recently announced success achieved during the third round of trials at its research facility at Queen's University (Kingston Ontario, Canada) Medizone International, Inc. announces that a second patent application has been filed which in combination with its previous patent application for AsepticSure™ filed in July of 2009, affords the Company greatly enhanced protection for both the hospital version of AsepticSure™ and the government variant intended for bio-terrorism countermeasures.
According to experts a simple DNA test for Down syndrome could save nearly all pregnant women from invasive tests like amniocentesis. Usually 3% to 5% of pregnant women in the UK or some 30,000 women have to undergo invasive tests like amniocentesis that increases the risk of miscarriage to 1%. The new DNA blood test could bring this down to 0.1%, according to a study in the British Medical Journal.
The head of the U.S. Food and Drug Administration has proposed charging compounding pharmacies fees to pay for the oversight needed to prevent a recurrence of the meningitis outbreak that killed 50 people and sickened hundreds more.
› Verified 3 days ago